Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04737187 |
|---|---|
| Brief Title: | Phase III Study of Trifluridine/Tipiracil With and Without Bevacizumab in Refractory Metastatic Colorectal Cancer Patients (SUNLIGHT) |
| First Submitted : | January 29, 2021 |
| First Submitted that Met QC Criteria : | February 2, 2021 |
| First Posted : | February 3, 2021 |
| Results First Submitted : | October 17, 2023 |
| Results First Posted with QC Comments : | November 13, 2023 |
| Results First Submitted that Met QC Criteria : | December 5, 2023 |
| Results First Posted : | December 26, 2023 |
| Certification/Extension First Submitted : | July 12, 2023 |
| Certification/Extension First Posted : | December 26, 2023 |
| Last Update Submitted that Met QC Criteria : | December 5, 2023 |
| Last Update Posted : | December 26, 2023 |